Method Validation for Quantification of PFOS and PFOA in Human Plasma and a Pilot Study in Blood Donors from Thai Red Cross Society

被引:0
|
作者
Lertassavakorn, Teerapong [1 ,5 ]
Pholphana, Nanthanit [1 ,2 ]
Rangkadilok, Nuchanart [1 ,2 ]
Suriyo, Tawit [1 ,2 ]
Teeyapant, Punthip [3 ]
Satayavivad, Jutamaad [1 ,2 ,4 ]
机构
[1] Chulabhorn Res Inst, Lab Pharmacol, Bangkok 10210, Thailand
[2] MHESI, Ctr Excellence Environm Hlth & Toxicol EHT, OPS, Bangkok 10400, Thailand
[3] Chulabhorn Res Inst, Translat Res Unit, Bangkok 10210, Thailand
[4] Chulabhorn Grad Inst CGI, Environm Toxicol Program, Bangkok 10210, Thailand
[5] Mahidol Univ, Fac Publ Hlth, Dept Environm Hlth Sci, Bangkok 10400, Thailand
关键词
PFOS; PFOA; LC-MS/MS; human plasma; C8 HEALTH PROJECT; PERFLUOROALKYL SUBSTANCES; POLYFLUOROALKYL SUBSTANCES; ISOMER ANALYSIS; EXPOSURE; SERUM; ASSOCIATIONS; BIOMARKERS; OVERWEIGHT; CHINESE;
D O I
10.3390/toxics11121015
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Information regarding per- and polyfluorinated substances concentrations in biological samples from the Thai population was still lacking. A sensitive bioanalytical method was developed and validated for the quantification of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) levels in human plasma. Simple protein precipitation and LC-MS/MS techniques were used with stable isotope internal standards of C-13(8)-PFOS and C-13(8)-PFOA. The validated method followed the ICH bioanalytical validation guideline, and the results showed good accuracy, precision, and reproducibility. The validated analytical method was then applied to determine PFOS and PFOA concentrations in 50 human plasma samples from the National Blood Center, Thai Red Cross Society. The concentrations were found to be in ranges of <0.91-6.27 ng/mL for PFOS and <0.49-2.72 ng/mL for PFOA. PFOS was also measured separately for its isomers, and the geometric means of the linear isomer (L-PFOS) and branched isomer (br-PFOS) in plasma samples were at 1.85 and 0.41 ng/mL, respectively. Both PFOS and PFOA concentrations were lower in comparison to previous reports from other countries. The present study showed the application of our reliable method to determine PFOS and PFOA in biological samples in order to monitor the human exposure of both chemicals in Thailand.
引用
收藏
页数:13
相关论文
共 28 条
  • [1] Plasma PFOA and PFOS Levels, DNA Methylation, and Blood Lipid Levels: A Pilot Study
    Cheng, Xu
    Wei, Yue
    Zhang, Zefang
    Wang, Fei
    He, Jia
    Wang, Ruixin
    Xu, Yal i
    Keerman, Mulatibieke
    Zhang, Shiyang
    Zhang, Ying
    Bi, Jiao
    Yao, Jinqiu
    He, Meian
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2022, 56 (23) : 17039 - 17051
  • [2] Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors
    Olsen, Geary W.
    Mair, David C.
    Reagen, William K.
    Ellefson, Mark E.
    Ehresman, David J.
    Butenhoff, John L.
    Zobel, Larry R.
    CHEMOSPHERE, 2007, 68 (01) : 105 - 111
  • [3] Pilot study on levels of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in selected foodstuffs and human milk from Italy
    Guerranti, Cristiana
    Perra, Guido
    Corsolini, Simonetta
    Focardi, Silvano E.
    FOOD CHEMISTRY, 2013, 140 (1-2) : 197 - 203
  • [4] Bioanalytical Method Development and Validation of HPLC-VU Method for Quantification of Embelin from Human Plasma
    Nijsure, Amey
    Vassa, Shwetal
    Jethawa, Shraddha
    Ghotpagar, Rohan
    Patil, Manali
    Mulgund, Sugandha
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY RESEARCH, 2024, 11 (03): : 299 - 307
  • [5] LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring
    Canil, Giovanni
    Orleni, Marco
    Posocco, Bianca
    Gagno, Sara
    Bignucolo, Alessia
    Montico, Marcella
    Roncato, Rossana
    Corsetti, Serena
    Bartoletti, Michele
    Toffoli, Giuseppe
    PHARMACEUTICS, 2023, 15 (05)
  • [6] Development and validation of a simple, fast, and sensitive LC/MS/MS method for the quantification of oxfendazole in human plasma and its application to clinical pharmacokinetic study
    Bach, Thanh
    Bae, SoHyun
    D'Cunha, Ronilda
    Winokur, Patricia
    An, Guohua
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 171 : 111 - 117
  • [7] Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of Vemurafenib in Human Plasma: Application to a Human Pharmacokinetic Study
    Bihan, Kevin
    Sauzay, Chloe
    Goldwirt, Lauriane
    Charbonnier-Beaupel, Fanny
    Hulot, Jean-Sebastien
    Funck-Brentano, Christian
    Zahr, Noel
    THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 132 - 136
  • [8] Development and validation of LC-MS/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study
    Prathipati, Pavan Kumar
    Mandal, Subhra
    Destache, Christopher J.
    BIOMEDICAL CHROMATOGRAPHY, 2019, 33 (02)
  • [9] Method validation studies and an inter-laboratory cross validation study of lenvatinib assay in human plasma using LC-MS/MS
    Mano, Yuji
    PRACTICAL LABORATORY MEDICINE, 2018, 12
  • [10] Development and validation of an LC-ESI-MS/MS method for the simultaneous quantification of naproxen and sumatriptan in human plasma: application to a pharmacokinetic study
    Juliana Machado Brêtas
    Isabela Costa César
    Camila Machado Brêtas
    Leonardo de Souza Teixeira
    Karini Bruno Bellorio
    Iram Moreira Mundim
    Gerson Antônio Pianetti
    Analytical and Bioanalytical Chemistry, 2016, 408 : 3981 - 3992